Compounded tirzepatide is designed to act on both GIP and GLP-1 receptor pathways, with a 6-step titration protocol personalized by your provider.
From $99/mo with 12-month planPlan availability and pricing vary by state. California has its own pricing, confirmed during your assessment.
Start Assessment →
Tirzepatide targets both GIP and GLP-1 receptors, the dual action associated with studied outcomes in clinical trials for chronic weight management, individual results vary in published trials.
Gradual increases from 2.5mg up to 15mg weekly, adjusted by your provider based on response and tolerability.
Weekly subcutaneous injection with B-vitamin co-formulation, prescribed after provider review.
Message your care team anytime with questions. If clinically appropriate, your provider may adjust your dose or treatment plan. Refills are managed online and reviewed by a provider when required or when your treatment changes.
Dosing starts low and increases gradually. Your provider adjusts each step based on your response and tolerability.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It acts on two incretin pathways involved in appetite and glucose metabolism.
A 5-minute online health questionnaire, no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
Your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose questions, refill reviews, and adjustments are handled online when clinically appropriate.
Your assessment takes about 5 minutes. A licensed provider takes it from there.
Start Assessment →
Compounded semaglutide, the same active ingredient studied in GLP-1 research, with a 5-step titration…